2026 Q2 Portfolio Activity
In 2026 Q2, Medicxi Ventures Management (Jersey) Ltd maintained a portfolio of 4 distinct positions. Conversely, Medicxi Ventures Management (Jersey) Ltd completely exited their position in CENTESSA PHARMACEUTICALS PLC.
Position History
hover any row below to update
Loading…
Total Positions
4
Quarter
2026 Q2
Top Holding
PHAT (45.6%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-4 of 4
Medicxi Ventures Management (Jersey) Ltd Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 45.65% | 8.45% |
#1
2
Prev: #3
|
7.0 |
—
|
no change | no change |
P
S
|
7,464,572 | $80,990,606 |
$16.83
-50.1%
|
2019 Q4 | 13F Filing | 2026-06-30 | 2026-08-04 | ||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 42.19% | 8.72% |
#2
Prev: #2
|
6.0 |
—
|
-465,543 | -17.4% |
P
S
|
2,208,639 | $74,850,776 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-04 | |||
|
AURA
AURA BIOSCIENCE...
|
Healthcare | 12.16% | 2.07% |
#3
1
Prev: #4
|
6.0 |
—
|
no change | no change |
P
S
|
3,039,892 | $21,583,233 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-04 | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 0.00% | 80.76% |
Sold All 😨
(Was: #1) |
0.0 |
—
|
-19,963,157 | -100.0% |
CLOSED
|
— | $— | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-04 |
Showing 1-4 of 4 holdings